Our mission is to ensure worker safety and operational efficiency through the strategic deployment of advanced technology.
At Bridgecrest Medical, we provide actionable intelligence to heavy industry professionals, to ensure safe and smooth operations. Our solutions combine the latest in mobile and wearable technology with real-time data analytics to help companies prevent accidents, lower insurance costs and increase productivity.
Based in San Francisco, we deploy our solutions for clients around the globe. Our end-to-end solutions integrate the first-hand expertise of world-class leaders in mobile technology, data analytics, occupational health and high-altitude medicine. We work with leading research institutions such as the Scripps Translational Science Institute and Universidad Católica de Santa María. We develop vertically-integrated Internet of Things (IoT) solutions through collaboration with organizations like Acceleprise and leading technologists in Silicon Valley.
Named one of the top nine healthcare tech startups to watch by Information Week, we work to ensure that the right insights reach the right person at the right time — to prevent accidents, lower insurance costs and increase productivity.
Sandy is Co-Founder and Managing Director at Horizon Partners. He was an early investor in Palantir Technologies, a company that makes products for human-driven analysis of real-world data — to help public and private-sector clients answer their most complex and urgent questions. He has also invested in a number of leading startups, such as Sprig, True Link and Sapho. Sandy’s company, Horizon Partners, helps mid-market companies raise capital and execute mergers and acquisitions. He received a B.A. in Psychology and M.S. in Management Science & Engineering from Stanford University.
Karen is Senior Vice President, Industry at Box, Inc. and Founder of Box.org. She is responsible for defining and leading Box’s Industry go-to-market strategy. She works to expand Box’s penetration into Fortune 1000 companies, establish government relations programs and initiatives, and run not-for-profit and corporate social responsibility efforts. Karen is a Trustee of the Computer History Museum and has been named one of the Top 10 Business Women in Enterprise 2.0. She holds a B.S. in International Business and Marketing from Towson University and a Master of Administrative Science in Organizational Development from Johns Hopkins University.
Michael is Managing Director of Acceleprise San Francisco, an enterprise software focused accelerator and investment fund. Acceleprise selects early-stage B2B companies and guides them through the process of developing scalable and repeatable processes to fuel growth. Michael led business development at Box (where he was one of the very first employees) and AcademixDirect. Passionate about building a strong community around early stage SaaS companies, he leads the San Francisco Enterprise Technology Meetup. He graduated with an MBA in Finance and Marketing from Columbia Business School and a B.S. in Mechanical Engineering from Syracuse University.
David is Founder and Managing Director of Right Side Capital Management, a seed-stage investment fund. He has 16 years of experience as Founder & CEO of two successful technology companies, Acorn Computer and WorkMetro. His goal at Right Side Capital Management is to change the way in which seed-stage technology companies get funded, to add more transparency and efficiency into a highly fragmented market — to stimulate innovation, draw more high-quality entrepreneurs into the market and provide greater investment returns. He graduated from Stanford University with a B.S. in Values, Technology, Science and Society with a focus on Artificial Intelligence.
|Dr. Steven Steinhubl
Dr. Steinhubl is the Director of Digital Medicine at the Scripps Translational Science Institute and a cardiologist at Scripps Health, Scripps Clinic. Dr. Steinhubl’s research activities have covered a broad range of topics in cardiology with a primary early focus on trials of novel antithrombotic therapies for the treatment and prevention of cardiovascular disease, and more recently on the application of an integrated systems-based approach to the optimal identification, communication and treatment of an individual’s risk for various manifestations of cardiovascular disease. He has been principal investigator or helped lead over a dozen large-scale, international randomized trials and has authored nearly 200 peer-reviewed manuscripts as well as numerous book chapters, and abstracts. He received his undergraduate training in chemical engineering at Purdue University in Indiana, graduate training in physiology at Georgetown University in Washington, DC, and his medical degree at St. Louis University in Missouri.
David is a seasoned marketing and sales executive with a passion for building businesses. He served as Chief Marketing Officer and VP of Sales for the Americas at Sensear, where he built and scaled a technology company serving heavy industry customers. David has had a diverse career: he launched new consumer products in the UK and built global consumer brands in Australia working for leading global marketing and advertising companies. Since moving to Silicon Valley he has advised hundreds of offshore entrepreneurs, developed partnerships in South America. He graduated from Australia’s Monash University.
Anubhav Srivastava profiles Bridgecrest Medical alongside Glow, Flatiron Health and Butterfly Network.
“… some unique ventures are using the power of big data, marrying it with communication technology, to address the R&D challenges related to diagnosis and analysis. Such startups do not make a lot of noise everyday with high valuations or increasing footprint, but nothing can deny that these are likely to have one of the most long lasting impact on our lives.” [Read more]
In her article for Fusion, Daniela Hernandez features Bridgecrest Medical in her analysis of a new trend in healthcare analytics: insta-mapping.
“The quick diagnoses paired with mapping is potentially a game changer. It has the potential to do for healthcare what smartphone location tracking did for traffic reports, so health workers will be able to better see ‘disease traffic.’ And for the biotech companies, it means they’ll know where their tests will sell.” [Read more]
9 Healthcare Tech Startups To Watch
As venture capital flows into healthcare startups, look at some new companies that should be on your radar.
“We chose to provide infectious disease tracking with our platform from day one because we knew it meant a lot to our customers. At a mine site, for example, an infectious disease outbreak can stop production in its tracks,” founder Nathan Klarer told InformationWeek.
“When the Ebola outbreak happened this year, we were uniquely positioned to rapidly deploy our solution because of this,” he continued. “We realized this was a good opportunity to offer an enterprise quality infectious disease analytics solution to a broad audience of organizations in need.”
While much of the Ebola panic has quieted in the United States, the disease continues to ravage populations in West Africa. And, unfortunately, plenty of other contagious diseases — including the flu — affect millions of people across the globe each year. [Read more]